After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, BBIO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of BridgeBio Pharma Inc is $6.50B. A total of 2.97 million shares were traded on the day, compared to an average of 2.97M shares.
In the most recent transaction, Kumar Neil sold 75,000 shares of BBIO for 33.40 per share on May 20 ’25. After the transaction, the Chief Executive Officer now owns 4,798,447 company shares. In a previous transaction on May 19 ’25, Kumar Neil sold 26,156 shares at 33.33 per share. BBIO shares that Chief Executive Officer owns now total 217,404.
Among the insiders who bought shares, NEIL KUMAR acquired of 26,156 shares on May 19 ’25 at a per-share price of $33.84. In another insider transaction, KKR Genetic Disorder L.P. sold 6,000,000 shares at $34.20 per share on May 12 ’25. Company shares held by the 10% Owner now total 13,260,971.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BBIO has a high of $39.54 and a low of $21.62.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BBIO’s latest balance sheet shows that the firm has $836.66M in Cash & Short Term Investments as of fiscal 2021. There were $1.73B in debt and $135.07M in liabilities at the time. Its Book Value Per Share was -$8.68, while its Total Shareholder’s Equity was -$865.58M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BBIO is Buy with a score of 4.72.
